Ultragenyx Pharmaceutical (MEX:RARE) Land And Improvements : MXN0 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ultragenyx Pharmaceutical Land And Improvements?

Ultragenyx Pharmaceutical's land and improvements for the quarter that ended in Jun. 2024 was MXN0 Mil.

Ultragenyx Pharmaceutical's quarterly land and improvements declined from Dec. 2023 (MXN282 Mil) to Mar. 2024 (MXN0 Mil) but then stayed the same from Mar. 2024 (MXN0 Mil) to Jun. 2024 (MXN0 Mil).

Ultragenyx Pharmaceutical's annual land and improvements increased from Dec. 2021 (MXN318 Mil) to Dec. 2022 (MXN324 Mil) but then declined from Dec. 2022 (MXN324 Mil) to Dec. 2023 (MXN282 Mil).

Ultragenyx Pharmaceutical Land And Improvements Historical Data

The historical data trend for Ultragenyx Pharmaceutical's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultragenyx Pharmaceutical Land And Improvements Chart

Ultragenyx Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

233.17

317.70

324.00

282.10

Ultragenyx Pharmaceutical Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Land And Improvements	Get a 7-Day Free Trial															-	-	282.10	-	-

Ultragenyx Pharmaceutical Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Ultragenyx Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultragenyx Pharmaceutical Inc (MEX:RARE) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

RARE:USA 0LIF:UK UP0:Germany

Address

60 Leveroni Court, Novato, CA, USA, 94949

Website

https://www.ultragenyx.com

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.